Get the Stockscreener App
5.14
1.78%
0.09
Pre-market:
5.08
-0.06
-1.17%
Embecta Corp stock is traded at $5.14, with a volume of 2.77M.
It is up +1.78% in the last 24 hours and up +41.21% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$5.05
Open:
$5
24h Volume:
2.77M
Relative Volume:
1.43
Market Cap:
$291.23M
Revenue:
$1.04B
Net Income/Loss:
$111.90M
P/E Ratio:
2.609
EPS:
1.9701
Net Cash Flow:
$205.80M
1W Performance:
+3.01%
1M Performance:
+41.21%
6M Performance:
-49.90%
1Y Performance:
-64.50%
1-Day Range:
$4.92
$5.235
1-Week Range:
$4.80
$5.235
52-Week Range:
$2.77
$15.55
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
300 KIMBALL DRIVE, PARSIPPANY
Compare EMBC vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
5.14 | 309.93M | 1.04B | 111.90M | 205.80M | 1.9701 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
EBIT per share of Embecta Corporation – HAM:JX7 - TradingView
Embecta Corporation Balance Sheet – HAM:JX7 - TradingView
Embecta (EMBC) Q3 2026 Earnings Call Transcript - AOL.com
Law firm probes Embecta directors for possible breach of fiduciary duty to shareholders - Pluang
EMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty - TMX Newsfile
EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop - TradingView
EMBC DEADLINEFINAL REMINDER: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Embecta Corp. to Contact the Firm Today! - ACCESS Newswire
EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit - Morningstar
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - AOL.com
Embecta Investors Face Class Action Deadline - stl.news
Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law - Business Wire
EMBC Court News: Embecta Securities Fraud Class Action - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - PR Newswire
Embecta Corp. Sued for Securities Law ViolationsFINAL DEADLINE TODAYEMBC - TradingView
EMBC DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
EMBC DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Embecta Corp. Investors to Participate in the Class Action Lawsuit Today - ACCESS Newswire
Liquidity Mapping Around (EMBC) Price Events - Stock Traders Daily
EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
EMBC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Embecta Corp. (EMBC) Notice of August 17, 2026 Deadline in Class Action Lawsuit – Hagens Berman - globenewswire.com
Kaplan Fox Continues to Remind Embecta Corp. (NASDAQ: EMBC) Investors of the Lead Plaintiff Deadline on August 17, 2026 - Barchart.com
Embecta Corp. (EMBC) Investors: August 17, 2026 Lead Plaintiff Deadline in Class Action LawsuitHagens Berman - Finansavisen
EMBECTA CORP. DEADLINE MONDAY AUGUST 17th: Embecta Corp. - GlobeNewswire
CLASS ACTION DEADLINE MONDAY NIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - FinancialContent
Kaplan Fox Alerts Embecta Corp. (NASDAQ: EMBC) Investors Who Suffered Losses to a Securities Class Action – Deadline is August 17, 2026 - The Globe and Mail
EMBC Shareholder Alert: August 17, 2026 Lead Plaintiff Deadline in Embecta Corp. Securities ... - Caledonian Record
EMBC Shareholder Alert: August 17, 2026 Lead Plaintiff - GlobeNewswire
Embecta Corp. SVP Elguicze purchases $93,360 in common stock By Investing.com - Investing.com South Africa
Embecta CEO Devdatt Kurdikar buys $140,937 in company stock By Investing.com - Investing.com Australia
Embecta CEO Devdatt Kurdikar buys $140,937 in company stock - Investing.com
Insider Spends US$141k Buying More Shares In Embecta - simplywall.st
EMBC Class Reminder: BFA Law Reminds Embecta Investors of - GlobeNewswire
Kaplan Fox Continues to Remind Embecta Corp. (NASDAQ: EMBC) Inves - The National Law Review
Embecta director Robert Hombach acquires $223.8k in common stock By Investing.com - Investing.com South Africa
Kaplan Fox Continues to Alert Investors of Embecta Corp. (NASDAQ - The National Law Review
Kaplan Fox Continues to Alert Investors of a Securities Class Act - The National Law Review
EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
EMBC 4-DAY DEADLINE ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitHagens Berman - TMX Newsfile
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on August 17, 2026 against Embecta Corp. (NASDAQ: EMBC) - Barchart.com
EMBC Shareholder Alert: Embecta Corp. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - Morningstar
EMBC DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Embecta Corp. Investors to Secure ... - Caledonian Record
EMBC DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, - GlobeNewswire
EMBC Deadline: Rosen Law Firm Urges Embecta Corp. (NASDAQ: EMBC) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Embecta president, pharmaceutical services & products management, CLO Jeffrey Mann buys $99,800 in stock - Investing.com Nigeria
Kaplan Fox Continues to Alert Investors of Embecta Corp. (NASDAQ: EMBC) to a Class Action Deadline on August 17, 2026 - Barchart.com
Insider Buying: Embecta (NASDAQ:EMBC) CEO Acquires 30,000 Shares of Stock - MarketBeat
Embecta director Robert Hombach acquires $223.8k in common stock - Investing.com
Insider Buying: Embecta (NASDAQ:EMBC) CFO Acquires $93,400.00 in Stock - MarketBeat
Jeffrey Mann Purchases 20,000 Shares of Embecta (NASDAQ:EMBC) Stock - MarketBeat
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Embecta Corp Stock (EMBC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Elguicze Jacob | SVP and CFO |
Aug 12 '26 |
Buy |
4.67 |
20,000 |
93,360 |
309,139 |
| Mann Jeffrey Z | Pres, Pharm Svc&Prod Mgmt, CLO |
Aug 12 '26 |
Buy |
4.99 |
20,000 |
99,800 |
262,915 |
| HOMBACH ROBERT J. | Director |
Aug 12 '26 |
Buy |
4.97 |
45,000 |
223,848 |
109,587 |
1.40%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):